Stemson and Bosley Parent Company, Aderans, Sign Exclusive Hair Regeneration Licensing Deal
March 8, 2024
Stemson Therapeutics and Aderans Company, the parent company of Bosley and HAIRCLUB, today announced an agreement securing Stemson the exclusive global rights to research, develop, and commercialize hair regeneration therapeutic products based on Aderans’ proprietary hair regeneration cell therapy technology. Stemson will resume Aderans’ Phase 2 clinical stage cell therapy hair regeneration program, integrate the technology into its existing hair loss cell therapy development pipeline, and provide multiple products for patients experiencing hair loss.